HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hidekatsu Yoshioka Selected Research

pro-alpha3(V) collagen

6/2005Pro-alpha3(V) collagen chain is expressed in bone and its basic N-terminal peptide adheres to osteosarcoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hidekatsu Yoshioka Research Topics

Disease

5Fabry Disease (Fabry's Disease)
12/2013 - 11/2004
3Radiation Fibrosis Syndrome (Radiation Fibrosis)
01/2021 - 02/2012
3Fibrosis (Cirrhosis)
01/2018 - 09/2007
3Wounds and Injuries (Trauma)
04/2011 - 01/2006
3Osteosarcoma (Osteogenic Sarcoma)
04/2010 - 06/2005
2Proliferative Vitreoretinopathy
01/2012 - 07/2004
2Neoplasms (Cancer)
09/2009 - 04/2004
2Body Weight (Weight, Body)
03/2009 - 09/2007
2Pulmonary Fibrosis (Fibrosing Alveolitis)
09/2007 - 01/2007
2Rhabdomyosarcoma
06/2006 - 06/2005
1Albuminuria
12/2013
1Polyuria
12/2013
1Stomach Neoplasms (Stomach Cancer)
07/2011
1Metaplasia
07/2011
1Bullous Pemphigoid (Pemphigoid)
11/2010
1Hepatocellular Carcinoma (Hepatoma)
09/2009
1Hyperthermia
09/2007
1Acute Lung Injury
09/2007
1Embryonal Rhabdomyosarcoma
06/2006
1Chondrosarcoma
06/2005
1Prostatic Neoplasms (Prostate Cancer)
03/2005
1Pilomatrixoma
04/2004

Drug/Important Bio-Agent (IBA)

5CollagenIBA
01/2021 - 04/2004
5Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2004
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 07/2004
3GalactosidasesIBA
12/2013 - 02/2011
3globotriaosylceramide (globotriosylceramide)IBA
12/2013 - 03/2009
3Extracellular Matrix ProteinsIBA
01/2012 - 07/2004
3GlycosphingolipidsIBA
02/2011 - 11/2004
3Messenger RNA (mRNA)IBA
09/2009 - 04/2004
3Collagen Type III (Type III Collagen)IBA
09/2007 - 06/2006
2Collagen Type I (Type I Collagen)IBA
01/2018 - 02/2012
2NucleotidesIBA
01/2018 - 04/2010
2EnzymesIBA
04/2013 - 11/2004
2alpha-Galactosidase (Beano)IBA
03/2009 - 11/2004
2migalastatIBA
03/2009 - 11/2004
2DNA (Deoxyribonucleic Acid)IBA
03/2006 - 06/2005
1MicroRNAs (MicroRNA)IBA
01/2018
1Dihydrotachysterol (AT 10)IBA
12/2013
1Urea (Carbamide)FDA LinkGeneric
12/2013
1Neutral GlycosphingolipidsIBA
12/2013
1NitrogenIBA
12/2013
1globotriaosyl lysosphingolipidIBA
04/2013
1SterigmatocystinIBA
07/2011
1Proliferating Cell Nuclear Antigen (PCNA)IBA
07/2011
1FibrinIBA
04/2011
1UDP-galactose-lactosylceramide alpha 1-4-galactosyltransferaseIBA
02/2011
1AutoantigensIBA
11/2010
1Keratins (Keratin)IBA
11/2010
1PlakinsIBA
11/2010
1epiplakinIBA
11/2010
1PlectinIBA
11/2010
1plerixaforFDA Link
09/2009
1LigandsIBA
09/2009
1SolutionsIBA
09/2007
1Saline SolutionIBA
09/2007
1LipopolysaccharidesIBA
09/2007
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
09/2007
1ElementsIBA
03/2006
1Keratin-6 (Keratin 6A)IBA
01/2006
1Heparin (Liquaemin)FDA LinkGeneric
06/2005
1pro-alpha3(V) collagenIBA
06/2005
1Peptides (Polypeptides)IBA
06/2005
1Biomarkers (Surrogate Marker)IBA
03/2005
1Prostate-Specific Antigen (Semenogelase)IBA
03/2005
1LuciferasesIBA
03/2005
1Transcription Factors (Transcription Factor)IBA
03/2005
1Drinking WaterIBA
11/2004
1Transforming Growth Factor beta (TGF-beta)IBA
07/2004
1Collagen Type II (Type II Collagen)IBA
04/2004
1SaltsIBA
04/2004
1Bone Morphogenetic Protein 2IBA
04/2004

Therapy/Procedure

3Therapeutics
12/2013 - 11/2004
1Oral Administration
11/2004